CN Mobile Logo

Search form


Ethics in Oncology

Ethics in Oncology

In this Q&A we examine Right-to-Try drug laws and discuss tips for clinicians with terminally ill patients who have exhausted all their therapy options.

One of the more difficult topics to discuss concerning the ethics of healthcare is distributive justice—the fair distribution of benefits, risks, and costs.

A delirious head and neck cancer patient does not have the capacity to make treatment decisions. Can we begin palliative radiation therapy without his consent?

Should I give a patient with a carcinoma of unknown primary another dose of a study drug, since she is requesting to continue it? My reading of the trial protocol suggests no absolute restriction on giving another dose of the drug.

I was recently consulted concerning a patient in the ICU at my hospital with advanced breast cancer, but I soon realized there were much larger issues at stake. This woman is in her 50s and was diagnosed approximately 1 year ago with metastatic triple-negative breast cancer.

With the boom of technological advances and the increased use of social media come the potential ethical issues surrounding patient privacy and confidentiality.

In a case of a patient with impaired decision-making, is the physician obligated to go through with a transplant when the transplant-related mortality would be on the order of 50%, and possibly as high as 80%?


Subscribe to Ethics in Oncology on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.